Literature DB >> 16521051

Acute myocardial infarction in systemic sclerosis patients: a case series.

Chris T Derk1, Sergio A Jimenez.   

Abstract

To characterize the clinical manifestations of patients with systemic sclerosis who develop a myocardial infarction (MI), a retrospective review of the medical records of all patients who were admitted to our institution between 1982 and 2002 and had the dual diagnosis of systemic sclerosis and an acute MI was done. From 1,009 systemic sclerosis hospital admissions, 11 (1.09%) were for an acute MI. Three of these patients had normal coronaries, and instead of wall motion abnormalities, left ventricular hypertrophy was the predominant finding of an echocardiography. The odds ratio of finding normal coronaries in systemic sclerosis vs the general population who develops an acute MI is 33.89 (14.08-81.39). Seven of our patients had an elevated creatinine level on presentation. Acute MI is an uncommon manifestation in systemic sclerosis patients. Normal coronaries are seen more commonly in these patients as compared to the general population, while vascular, gastrointestinal, and renal involvement is prevalent in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521051     DOI: 10.1007/s10067-006-0211-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries.

Authors:  P Ammann; S Marschall; M Kraus; L Schmid; W Angehrn; R Krapf; H Rickli
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

2.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

3.  Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

Authors:  E L Alexander; G S Firestein; J L Weiss; R R Heuser; G Leitl; H N Wagner; J A Brinker; A A Ciuffo; L C Becker
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

4.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

5.  Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients.

Authors:  E V Lally; S A Jimenez; S R Kaplan
Journal:  Semin Arthritis Rheum       Date:  1988-08       Impact factor: 5.532

6.  Myocardial infarction in young adults under 30 years: risk factors and clinical course.

Authors:  I Weinberger; Z Rotenberg; J Fuchs; A Sagy; J Friedmann; J Agmon
Journal:  Clin Cardiol       Date:  1987-01       Impact factor: 2.882

7.  Myocardial infarction with angiographically normal coronary arteries.

Authors:  M Sharifi; T G Frohlich; I M Silverman
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

8.  Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

Authors:  R J Eason; P L Tan; P J Gow
Journal:  Aust N Z J Med       Date:  1981-12

9.  Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis.

Authors:  B H Bulkley; P G Klacsmann; G M Hutchins
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

10.  [Cardiac disorders associated with progressive systemic sclerosis].

Authors:  N Hata; T Kunimi; H Matsuda; S Nagaoka; A Aoki; S Odelmat
Journal:  J Cardiol       Date:  1998-12       Impact factor: 3.159

View more
  9 in total

Review 1.  Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Prangthip Charoenpong; Praveen Ratanasrimetha; Charat Thongprayoon; Wisit Cheungpasitporn; Promporn Suksaranjit
Journal:  Clin Rheumatol       Date:  2014-05-25       Impact factor: 2.980

Review 2.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 3.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

Review 4.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

5.  Mistaken identity: normotensive scleroderma renal crisis.

Authors:  Arwa Aburizik; Siddharth Singh; Laith Al-Rabadi; Christopher Blosser
Journal:  BMJ Case Rep       Date:  2014-05-29

Review 6.  Cardiovascular disease in systemic sclerosis--an emerging association?

Authors:  Gene-Siew Ngian; Joanne Sahhar; Ian P Wicks; Sharon Van Doornum
Journal:  Arthritis Res Ther       Date:  2011-08-26       Impact factor: 5.156

Review 7.  Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.

Authors:  Sergio A Jimenez
Journal:  ISRN Rheumatol       Date:  2013-09-23

8.  Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.

Authors:  Stylianos Panopoulos; Maria Tektonidou; Alexandros A Drosos; Stamatis-Nick Liossis; Theodoros Dimitroulas; Alexandros Garyfallos; Lazaros Sakkas; Dimitrios Boumpas; Paraskevi V Voulgari; Dimitrios Daoussis; Konstantinos Thomas; Georgios Georgiopoulos; Georgios Vosvotekas; Dimitrios Vassilopoulos; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2018-12-04       Impact factor: 5.156

9.  Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.

Authors:  Annica Nordin; Kerstin Jensen-Urstad; Lena Björnådal; Susanne Pettersson; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2013-08-14       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.